Toth Financial Advisory’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $59.4K | Hold |
|
|||||
|
2025
Q2 | $45.7K | Sell |
|
|||||
|
2025
Q1 | $271K | Sell |
|
|||||
|
2024
Q4 | $439K | Sell |
|
|||||
|
2024
Q3 | $730K | Sell |
|
|||||
|
2024
Q2 | $750K | Sell |
|
|||||
|
2024
Q1 | $1.5M | Buy |
|
|||||
|
2023
Q4 | $641K | Buy |
|
|||||
|
2023
Q3 | $460K | Sell |
|
|||||
|
2023
Q2 | $515K | Buy |
|
|||||
|
2023
Q1 | $493K | Sell |
|
|||||
|
2022
Q4 | $979K | Buy |
|
|||||
|
2022
Q3 | $359K | Sell |
|
|||||
|
2022
Q2 | $392K | Sell |
|
|||||
|
2022
Q1 | $598K | Sell |
|
|||||
|
2021
Q4 | $810K | Sell |
|
|||||
|
2021
Q3 | $2.01M | Buy |
|
|||||
|
2021
Q2 | $1.52M | Buy |
|
|||||
|
2021
Q1 | $855K | Sell |
|
|||||
|
2020
Q4 | $1.86M | Sell |
|
|||||
|
2020
Q3 | $1.51M | Sell |
|
|||||
|
2020
Q2 | $1.8M | Buy |
|
|||||
|
2020
Q1 | $852K | Buy |
|
|||||
|
2019
Q4 | $441K | Buy |
|
|||||
|
2019
Q3 | $282K | Sell |
|
|||||
|
2019
Q2 | $352K | Sell |
|
|||||
|
2019
Q1 | $527K | Buy |
|
|||||
|
2018
Q4 | $376K | Sell |
|
|||||
|
2018
Q3 | $1.95M | Buy |
|
|||||
|
2018
Q2 | $1.6M | Sell |
|
|||||
|
2018
Q1 | $1.56M | Buy |
|
|||||
|
2017
Q4 | $1.56M | Buy |
|
|||||
|
2017
Q3 | $1.7M | Buy |
|
|||||
|
2017
Q2 | $1.17M | Buy |
|
|||||
|
2017
Q1 | $1.06M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $790K | Buy |
|